SEC Form 4 · accession 0001225385-17-000108
PRECIGEN, INC. · PGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas D. Reed
Officer — Chief Science Officer
Period of report
Oct 16, 2017
Accepted (ET)
Oct 17, 2017 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356090
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 16, 2017 | M | 29,692 | $2.64 | A | 93,809 | D | |
| Common Stock | Oct 16, 2017 | M | 8,906 | $2.64 | A | 102,715 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock (Right to Buy)F1 | $2.64 | Oct 16, 2017 | M | 29,692 | D | — | Nov 15, 2017 | Common Stock | 29,692 | 0 | D |
| Option to Purchase Common Stock (Right to Buy)F1 | $2.64 | Oct 16, 2017 | M | 8,906 | D | — | Feb 20, 2018 | Common Stock | 8,906 | 0 | D |
Explanation of responses
- F1The option was immediately exercisable.